CD70-Targeted PET/CT in a Patient with von Hippel–Lindau Syndrome and Clear Cell Renal Cell Carcinoma

A 46-y-old man with genetically confirmed von Hippel–Lindau (VHL) syndrome presented for surveillance. He had previously been treated for cerebellar hemangioblastoma and underwent right partial nephrectomy 5 y earlier, with pathology confirming clear cell renal cell carcinoma (ccRCC). On follow-up

Authors

Institutions

Publication Details

Journal
Journal of Nuclear Medicine
Published
2026-10-15
DOI
https://doi.org/10.2967/jnumed.126.273553
Primary Topic
Renal cell carcinoma treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

CD70-Targeted PET/CT in a Patient with von Hippel–Lindau Syndrome and Clear Cell Renal Cell Carcinoma

Ailin Deng, Weijun Wei
Journal of Nuclear Medicine
Renal cell carcinoma treatment
article

CD70-Targeted PET/CT in a Patient with von Hippel–Lindau Syndrome and Clear Cell Renal Cell Carcinoma

Ailin Deng, Weijun Wei
article en

Abstract

A 46-y-old man with genetically confirmed von Hippel–Lindau (VHL) syndrome presented for surveillance. He had previously been treated for cerebellar hemangioblastoma and underwent right partial nephrectomy 5 y earlier, with pathology confirming clear cell renal cell carcinoma (ccRCC). On follow-up

Journal of Nuclear Medicine
Shanghai Jiao Tong University (CN), Renji Hospital (CN)
Good health and well-being
Openalex Percentile: Top 13%
Renal cell carcinoma treatment
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.